Hi-Tech Pharmaceuticals Inc. Recall: Unapproved Drug Claims and Misbranded.

🇺🇸 United States

1. August 6, 2025 - Recall initiated
2. September 24, 2025 - Reported by source
3. February 19, 2026 - Recall terminated

Official source record

Agency

FDA

Dataset

FDA Food Enforcement (Recalls)

Recall number

H-0593-2025

Event ID

97373

Status

Terminated

Classification

Class III

Company

Hi-Tech Pharmaceuticals Inc.

Product description

HI-TECH PHARMACEUTICALS SLIMAGLUTIDE REVOLUTIONARY WEIGHT LOSS AID WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONIST AND SECRETAGOGUES NOVEL GIP (GLUCOSE-DEPENDENT ISNULINOTROPIC POLYPEPTIDE) RECEPTOR AGONIST 180 TABLETS DIETARY SUPPLEMENT

Quantity

85,950 units total

Reason

Unapproved Drug Claims and Misbranded.

Recall initiation date

August 6, 2025

Report date

September 24, 2025

Classification date

Not published in this source record

Termination date

February 19, 2026

Distribution pattern

Product was shipped to the following states: AL, AR, AZ, CA, CO, CT, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV & WY.

UPC, lot, and code information

Lot C19El8 Exp Date 05/30

Voluntary or mandated

Voluntary: Firm initiated

Initial notification method

Letter

Source last updated

Not tracked separately from the Public Health Trace retrieval date below

Public Health Trace retrieval date

July 18, 2026 ET

Other products recalled under this same event

This recall shares FDA event ID 97373 with 9 other product entries in Public Health Trace.

Responsible company: Hi-Tech Pharmaceuticals Inc.

Other recalls from Hi-Tech Pharmaceuticals Inc.

A map highlighting the states named in the source's distribution description.

Distributed No data published

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map

State	Distributed
Alabama	1
Arkansas	1
Arizona	1
California	1
Colorado	1
Connecticut	1
Delaware	1
Florida	1
Georgia	1
Guam	1
Hawaii	1
Iowa	1
Idaho	1
Illinois	1
Indiana	1
Kansas	1
Kentucky	1
Louisiana	1
Massachusetts	1
Maryland	1
Michigan	1
Minnesota	1
Missouri	1
Mississippi	1
Montana	1
North Carolina	1
North Dakota	1
Nebraska	1
New Hampshire	1
New Jersey	1
New Mexico	1
Nevada	1
New York	1
Ohio	1
Oklahoma	1
Oregon	1
Pennsylvania	1
Puerto Rico	1
Rhode Island	1
South Carolina	1
South Dakota	1
Tennessee	1
Texas	1
Utah	1
Virginia	1
Vermont	1
Washington	1
Wisconsin	1
West Virginia	1
Wyoming	1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace: July 18, 2026 ET

Frequently asked questions

What does a Class III mean?

A situation in which use of or exposure to a product is not likely to cause adverse health consequences.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.

• Email
• X / Twitter
• Facebook